DZ-002

Da Zen Theranostics Inc · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	DZ-002
Sponsor	Da Zen Theranostics Inc
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

DZ-002 CI brief — competitive landscape report
DZ-002 updates RSS · CI watch RSS
Da Zen Theranostics Inc portfolio CI